Welcome to: Rimonabant Information Source (where can i get cheap rimonabant)

buy Rimonabant and lose weight
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 

Effective weight loss with Rimonabant

On rxslimming.com you can learn more about the beneficial effects of Acomplia. Acomplia, often known as rimonabant, is a revolutionary diet pill based on the so-called cannabino?-1-receptor blockers (CB-1). Since it was first discovered by the French drug maker Sanofi-Synthelabo, rimonabant is used to treat obesity and other related conditions. Generic Acomplia targets your CB-1 receptors, decreasing the activity of the endocannabino? system, thus suppressing your appetite. As a result, you won? ?˘ t feel the temptation to eat and lost so much weight will be an easy task. The use of rimonabant in combination with exercise and healthy diet is a good way to lose extra pounds quickly. Rxslimming.com offers the possibility of generic Acomplia online and save 70%.

Rimonabant Pricelist

Please wait while we load the price list
In today’s world, you’ll see on every magazine cover that beauty equals a slim figure. Many people with excessive weight problems feel left out and even depressed because of their condition. Obesity can lead to a lack of self confidence and isolation from the world. Furthermore, weighing much more than you should is bound to bring about serious health problems that deteriorate over time. If you want to lose weight but have trouble controlling your appetite, rimonabant is the perfect solution. Buy rimonabant online at rxslimming.com and you’ll be back into shape in no time. You’re probably wondering what is rimonabant and how can it help you lose weight? Also called Acomplia, this revolutionary diet pill has been developed by a French company and has been a big hit in Europe ever since.

5kg. The placebo-corrected loss for Acomplia in a similar trial was 0. 7kg. Related Results Lancet, BMJ studies sound concern over anti-obesity drug rimonabantRimonabant improves cardiovascular risk profileRimonabant improves cardiovascular risk profileNew drug application for rimonabant pulledRimonabant enhanced weight loss success, improved lipids US regulators have refused to license Acomplia, which is already available in parts of Europe, citing safety concerns, and particularly an increased risk of depression. Vernalis is hopeful that V24343 may avoid these problems, noting that it has a 'markedly reduced propensity' for neurological adverse events. COPYRIGHT 2007 Society of Chemical Industry COPYRIGHT 2008 Gale, Cengage Learning.